期刊文献+

Barrett食管组织HIF-1α、mtP53、IMP3蛋白表达及意义 被引量:3

The expression and clinical significance of HIF-1α,mtP53 and IMP3 in Barrett′s esophagus
在线阅读 下载PDF
导出
摘要 目的观察缺氧诱导因子-1α(HIF-1α)及mtP53、IMP3蛋白在Barrett食管中的表达情况,分析HIF-1α及mtP53、IMP3在Barrett食管发生、发展中的意义。方法取100例Barrett食管胃镜标本进行免疫组织化学分析HIF-1α、mtP53、IMP3蛋白的含量,并与50例反流性食管炎组织比较。结果与反流性食管炎组比较,Barrett食管组HIF-1α、mtP53、IMP3蛋白表达均明显增强(P<0.05),HIF-1α、mtP53、IMP3三者的表达呈正相关(均P<0.01)。结论 HIF-1α、mtP53、IMP3在Barrett食管的发生、发展中起着很大的作用,有可能是Barrett食管发生及恶变的机制之一。 Objective To observe the expression of hypoxia-inducible factor-1α(HIF-1α), mtP53, IMP3 protein in Barrett's esophagus tissue,and to analyze their significance. Methods The expression of HIF-1α,mtP53 and IMP3 in 100 patients with Bar- rett's esophagus gastroscopy specimens was detected with immunohistochemical method. Then compared with 50 cases of the Re- flux esophagitis tissue. Results Compared with the Reflux esophagitis group,the expressions of HIF-1α,mtP53 and IMP3 protein were significantly increased in the Barrett's esophagus group(P〈0.05). The expression of HIF-1α,mtP53 and IMP3 protein was also being related(all P〈0.01). Conclusion In the occurrence and development of Barrett's esophagus,HIF-1α and mtP53,IMP3 probably play a big role,There may be one of the mechanisms of deterioration and the origin of Barrett's esophagus.
出处 《重庆医学》 CAS CSCD 北大核心 2012年第31期3289-3290,F0003,共3页 Chongqing medicine
关键词 BARRETT食管 免疫组织化学 缺氧诱导因子-1Α MTP53 IMP3 Barrettr s esophagus immunohistochemicah hypoxia-inducihle factor-1α mtP53 IMP3
  • 相关文献

参考文献1

共引文献8

同被引文献42

  • 1Conover CA, Khosla S. Role of extracellular matrix in insulin-like growth factor (IGF) binding protein-2 regulation of IGF-II action in normal human osteoblasts. Growth Horm IGF Res 2003; 13: 328-335.
  • 2Chen K, Cornejo KM, Ye W, Wu Q, Liang J, Jiang Z. Oncofetal protein IMP3: a new diagnostic biomarker for laryngeal carcinoma. Hum Pathol 2013; 44: 2126-2131.
  • 3Lu D, Yang X, Jiang NY, Woda BA, Liu Q, Dresser K, Mercurio AM, Rock KL, Jiang Z. IMP3, a new biomarker to predict progression of cervical intraepithelial neoplasia into invasive cancer. Am J Surg Pathol 2011; 35: 1638-1645.
  • 4El-Serag HB, Marrero JA, Rudolph L, Reddy KR. Diagnosis and treatment of hepatocellular carcinoma. Gastroenterology 2008; 134: 1752-1763.
  • 5Roncalli M, Park YN, Di Tommaso L. Histopathological classification of hepatocellular carcinoma. Dig Liver Dis 2010; 42 Suppl 3: S228-S234.
  • 6Wachter DL, Kristiansen G, Soll C, Hellerbrand C, Breuhahn K, Fritzsche F, Agaimy A, Hartmann A, Riener MO. Insulin-like growth factor II mRNA-binding protein 3 (IMP3) expression in hepatocellular carcinoma. A clinicopathological analysis with emphasis on diagnostic value. Histopathology 2012; 60: 278-286.
  • 7Hu S, Wu X, Zhou B, Xu Z, Qin J, Lu H, Lv L, Gao Y, Deng L, Yin J, Li G. IMP3 combined with CD44s, a novel predictor for prognosis of patients with hepatocellular carcinoma. J Cancer Res Clin Oncol 2014; 140: 883-893.
  • 8Tosun Yildirim H, Sentürk N. Analysis of IMP3 expression in prostate adenocarcinomas. Turk Patoloji Derg 2012; 28: 128-133.
  • 9Beljan Perak R, Durdov MG, Capkun V, Ivcevic V, Pavlovic A, Soljic V, Peric M. IMP3 can predict aggressive behaviour of lung adenocarcinoma. Diagn Pathol 2012; 7: 165.
  • 10Gao Y, Yang M, Jiang Z, Woda BA, Mercurio AM, Qin J, Huang X, Zhang F. IMP3 expression is associated with poor outcome and epigenetic deregulation in intrahepatic cholangiocarcinoma. Hum Pathol 2014; 45: 1184-1191.

引证文献3

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部